Olfactory Toxicity of Methimazole: Dose-Response and Structure-Activity Studies and Characterization of Flavin-Containing Monooxygenase Activity in the Long-Evans Rat Olfactory Mucosa

Abstract

Methimazole is a compound administered to humans for the treatment of hyperthyroidism and is used experimentally as a model substrate for the flavin-containing monooxygenase (FMO) system. Previous results from this laboratory demonstrated that methimazole is an olfactory system toxicant, causing nearly complete destruction of the olfactory epithelium in the male Long-Evans rat following a single ip dose of 300 mg/kg. The present studies were undertaken to determine the dose-response relationship for methimazole-induced olfactory mucosal damage and to determine whether or not similar damage occurs as a result of oral administration, mimicking the relevant route of human exposure. We also investigated the mechanism of olfactory toxicity of methimazole by means of a structure-activity study and began the characterization of the form(s) of FMO present in the olfactory mucosa of the male Long-Evans rat. Dose-response analysis demonstrated that methimazole causes olfactory mucosal damage at doses of 25 mg/kg ip and greater. The results of gavage studies showed that a single oral dose of 50 mg/kg also caused olfactory mucosal damage. Two structurally related compounds, methylimidazole and methylpyrrole, were not olfactory toxicants, suggesting that a reactive intermediate generated in the course of metabolizing methimazole to an S-oxide is the olfactory toxic species. Microsomal incubation studies revealed the presence ofmethimazole S-oxidation activity in olfactory mucosal microsomes at levels comparable to those in liver. An anti-mouse liver FMO antibody reacted on Western blots with olfactory mucosal microsomes. These findings demonstrate a dose-response for the olfactory toxicity of methimazole and suggest that characterization of human olfactory mucosal FMO activity may be necessary to assess the potential for human risk associated with therapeutic exposure to methimazole.

Keywords

Flavin-containing monooxygenase (FMO)β,β'-iminodipropionitrile (IDPN)methimazole methylpyrrole methylimidazole olfactory mucosa

References

Blake BL , Philpot RM , Levi PE , and Hodgson E. (1995). Identification of novel FMO4 expression in rabbit brain. Biochem. Biophys. Res. Comm. (in press).

Brandt I. , Brittebo EB , Feil VJ , and Bakke JE (1990). Irreversible binding and toxicity of the herbicide dichlobenil (2,6-dichlorobenzonitrile) in the olfactory mucosa of mice. Toxicol. Appl. Pharmacol. 103: 491-501.

Brittebo EB (1987). Metabolic activation of phenacetin in rat nasal mucosa: Dose-dependent binding to the glands of Bowman. Cancer Res. 47: 1449-1456.

Brittebo EB , Eriksson C. , and Brandt I. (1990). Activation and toxicity of bromobenzene in nasal tissues in mice. Arch. Toxicol. 64: 54-60.

Connors JM (1990). Thyroid and antithyroid drugs. In: Modern Pharmacology, CR Craig and RE Stitzel (eds). Little, Brown and Co., Boston, pp. 910-923.

Cooper DS , Bode HH , Nath B. , Saxe V. , Maloof F. , and Ridgway EC (1984). Methimazole pharmacology in man: Studies using a newly developed radioimmunoassay for methimazole. J. Clin. Endocrinol. Metab. 58: 473-479.

Dahl AR and Hadley WH (1991). Nasal cavity enzymes involved in xenobiotic metabolism: Effects on the toxicity of inhalants. CRC Crit. Rev. Toxicol . 21: 345-372.

Deamer NJ , O'Callaghan JP , and Genter MB (1994). Olfactory toxicity resulting from dermal application of 2,6-dichlorobenzonitrile (dichlobenil) in the C57BI mouse. Neurotoxicology 15: 287-294.

Dixit A. and Roche TE (1984). Spectrophotometric assay of the flavin-containing monooxygenase and changes in its activity in female mouse liver with nutritional and diurnal conditions. Arch. Biochem. Biophys. 233: 50-63.

10.

Emeigh Hart SG , Cartun RW , Wyand DS , Khairallah EA , and Cohen SD (1995). Immunohistochemical localization of acetaminophen in target tissues of the CD-1 mouse: Correspondence of covalent binding with toxicity. Fundam. Appl. Toxicol. 24: 260-274.

11.

Genter MB , Deamer NJ , Cao Y. , and Levi PE (1994). Effects of P450 inhibition and induction on the olfactory toxicity of β,β'-iminodipropionitrile (IDPN) in the rat . J. Biochem. Toxicol. 9: 31-39.

12.

Genter MB , Llorens J. , O'Callaghan JP , Peele DB , Morgan KT , and Crofton KM (1992). Olfactory toxicity of β,β'-iminodipropionitrile (IDPN) in the rat. J. Pharmacol. Exp. Therap. 263: 1432-1439.

13.

Genter MB , Owens DM and Deamer NJ (1995). Distribution of microsomal epoxide hydrolase and glutathione S-transferase in the rat olfactory mucosa: Relevance to distribution of lesions caused by systemically-administered olfactory toxicants. Chem. Senses (in press).

14.

Genter MB , Zainal TA , and Deamer NJ (1994). Olfactory toxicity of methimazole: Results of intraperitoneal and oral dosing studies. Inh. Toxicol. 6(suppl.): 433-437.

15.

Gross EA , Mellick PW , Kari FW , Miller FJ , and Morgan KT (1994). Histopathology and cell replication responses in the respiratory tract of rats and mice exposed by inhalation to glutaraldehyde for up to 13 weeks. Fund. Appl. Toxicol. 23: 348-362.

16.

Haynes RC and Maurad F. (1985). Thyroid and antithyroid drugs. In: The Pharmacological Basis of Therapeutics, 7th ed., AG Gilman , LS Goodman , TW Rall , and F Murad (eds). Macmillan Publishing , New York, pp. 1408-1411.

17.

Jansson R. , Dahlberg PA , Johansson H. , and Lindstrom B. (1983). Intrathyroidal concentrations of methimazole in patients with Graves' disease. J. Clin. Endocrinol. Metab . 57: 129-132.

18.

Joyner DR , Fleishman A. , Gross EA , and Morgan KT (1995). Use of glycol methacrylate sections for determination of regional distribution of intravascularly-administered microspheres for study of regional nasal blood perfusion in the rat. Presented at the annual meeting of the North Carolina Society of Toxicology , Research Triangle Park, NC, February 1995.

19.

Kedderis GL and Rickert DE (1985). Loss of rat liver microsomal cytochrome P-450 during methimazole metabolism: Role of flavin-containing monooxygenase. Drug Metab. Disposition 13: 58-61.

20.

Lawton MP , Cashman JR , Cresteil T. , Dolphin CT , Elfarra AA , Hines RN , Hodgson E. , Kimura T. , Ozols J. , Phillips IR , Philpot RM , Poulson LL , Rettie AE , Shephard EA , Williams DE , and Ziegler DM (1994). A nomenclature for the mammalian flavin-containing monooxygenase gene family based on amino acid sequence identities. Arch. Biochem. Biophys. 308: 254-257.

21.

Lawton MP and Philpot RM (1993). Molecular genetics of the flavin-dependent monooxygenases . Pharmacogenetics 3: 40-44.

22.

Monticello TM , Miller FJ , and Morgan KT (1991). Regional increases in rat nasal epithelial cell proliferation following acute and subchronic inhalation of formaldehyde. Toxicol. Appl. Pharmacol. 111: 409-421.

23.

Morandi A. , Gambetti P. , Arora PK , and Sayre LM (1987). Mechanism of neurotoxic action of β,β'-iminodipropionitrile (IDPN): N-hydroxylation enhances neurotoxic potency. Brain Res. 437: 69-76.

24.

Poulsen LL , Hyslop RM and Ziegler DM (1979). S-oxidation of N-substituted thioureas catalyzed by the pig liver microsomal FAD-containing monooxygenase. Arch. Biochem. Biophys. 198: 78-88.

25.

Rangga-Tabbu C. and Sleight SD (1992). Sequential study in rats of nasal lesions induced by N-nitrosodimethylamine and N-nitorsopyrrolidine . Fundam. Appl. Toxicol. 19: 147-156.

26.

Reed CJ (1993). Drug metabolism in the nasal cavity: Relevance to toxicology. Drug Metab. Rev. 25: 173-205.

27.

Sabourin PJ and Dahl AR (1985). Distribution ofthe FAD-containing monooxygenase in respiratory tract tissues. In: Annual Report LMF-114, MA Medinsky and BA Muggenburg (eds). National Technical Information Service, Springfield, Virginia, pp. 156.

28.

Sabourin PJ and Hodgson E. (1984). Characterization of the purified microsomal FAD-containing monooxygenase from mouse and pig liver . Chem. Biol. Interact. 51: 125-139.

29.

Sabourin PJ , Smyser BP , and Hodgson E. (1984). Purification of the flavin-containing monooxygenase from mouse and pig liver microsomes. Int. J. Biochem. 16: 713-720.

30.

Shehin-Johnson SE , Williams DE , Larsen-SuS , Stresser DM , and Hines RN (1995). Tissue-specific expression of flavin-containing monooxygenase (FMO) forms 1 and 2 in the rabbit. J. Pharmacol. Exp. Therap. 272: 1293-1299.

31.

Shiroozu A. , Okamura K. , Ikenoue H. , Sato K. , Nakashima T. , Yoshinari M. , Fujishima M. , and Yoshizumi T. (1986). Treatment of hyperthyroidism with a small single daily dose of methimazole . J. Clin. Endocrinol. Metab. 63: 125-128.

32.

Smith PK , Krohn RI , Hermanson GT , Mallia AK , Gartner FH , Provenzano MD , Fujimoto EK , Goeke NM , Olson BJ , and Klenk DC (1985). Measurement of protein using bicinchoninic acid . Anal. Biochem. 150: 76-85.

33.

Turk MAM , Flory W. , and Henk WG (1986). Chemical modulation of 3-methylindole toxicosis in mice: Effect on bronchiolar and olfactory mucosal injury. Vet. Pathol. 23: 563-570.

34.

U.S. Department of Health and Human Services ( 1985). Guide for the Care and Use of Laboratory Animals. Animal Resources Program, Division of Research Resources, National Institutes of Health, Bethesda, MD.

35.

Venkatesh K. , Levi PE , and Hodgson E. (1991). The flavin-containing monooxygenase of mouse kidney: A comparison with the liver enzyme. Biochem. Pharmacol. 42: 1211-1420.

36.

Wolf DC , Morgan KT , Gross EA , Barrow C. , Moss OR , James AR , and Popp JA (1995). Two-year inhalation exposure of female and male B6C3F1 mice and F344 rats to chlorine gas induces lesions confined to the nose. Fund. Appl. Toxicol. 24: 111-131.

37.

Young JT (1981). Histopathologic examination of the rat nasal cavity . Fund. Appl. Toxicol. 1 : 309-312.

38.

Ziegler DM (1993). Recent studies on the structure and function of multisubstrate flavin-containing monooxygenases. Annu. Rev. Pharmacol. Toxicol. 33: 179-199.